Dr. Reddy's Laboratories Ltd. NSE: DRREDDY | BSE: 500124

Mid-range Performer

In 4 Starfolio Baskets

Download real time

1248.00 11.90 (0.96%)

840.3K

NSE+BSE Volume

NSE 26 Nov, 2025 3:31 PM (IST)

Regulatory Approval

Dr Reddy's gets EU approval for AVT03, a biosimilar to Prolia, with a market size of $1.2 bn See details

Dr. Reddy's Laboratories Ltd. quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents